| 11952360 |
Hill NJ, Levason W, Reid G: Arsenic (III) halide complexes with acyclic and macrocyclic thio- and selenoether coligands: synthesis and structural properties. Inorg Chem. 2002 Apr 22;41(8):2070-6.
The preparations of the new complexes [AsBr (3)[MeS (CH (2))(2) SMe]], [AsX (3)([9] aneS (3))] (X = Cl, Br or I; [9] aneS (3) = 1,4,7-trithiacyclononane), [AsCl (3)([14] aneS (4))] ([14] aneS (4) = 1,4,8,11-tetrathiacyclotetradecane), [AsX (3)([8] aneSe (2))] ([8] aneSe (2) = 1,5-diselenacyclooctane), [(AsX (3))(2)([16] aneSe (4))] ([16] aneSe (4) = 1,5,9,13-tetraselenacyclohexadecane), and [(AsBr (3))(2)([24] aneSe (6))] ([24] aneSe (6) = 1,5,9,13,17,21-hexaselenacyclotetracosane) are described. These are obtained from direct reaction of the appropriate AsX (3) and 1 mol equiv of the thio- or selenoether ligand in anhydrous CH (2) Cl (2) (or thf for X = I) solution. The products have been characterized by microanalysis and IR and (1) H NMR spectroscopy. In solution they are extensively dissociated, reflecting the weak Lewis acidity of AsX (3). Reaction of AsX (3) with MeSe (CH (2))(2) SeMe or MeC (CH (2) EMe)(3) (E = S or Se) gave only oils. Treatment of PCl (3) or PBr (3) with Me (2) S, MeE (CH (2))(2) EMe, or [9] aneS (3) failed to give solid complexes, and there was no evidence from NMR spectroscopy for any adduct formation in solution. The crystal structures of the first series of thioether and selenoether complexes of As (III) are described: [AsBr (3)[MeS (CH (2))(2) SMe]], C (4) H (10) AsBr (3) S (2), a = 10.2818 (6) A, b = 7.8014 (5) A, c = 14.503 (1) A, beta = 102.9330 (2) degrees, monoclinic, P2 (1)/c, Z = 4; [AsI (3)[MeS (CH (2))(2) SMe]], C (4) H (10) AsI (3) S (2), a = 9.1528 (1) A, b = 11.5622 (2) A, c = 12.0939 (2) A, beta = 93.863 (1) degrees, monoclinic, P2 (1)()/n, Z = 4; [AsCl (3)([9] aneS (3))], C (6) H (12) AsCl (3) S (3), a = 17.520 (4) A, b = 17.520 (4) A, c = 16.790 (7) A, tetragonal, I4 (1) cd, Z = 16; [AsCl (3)([14] aneS (4))], C (10) H (20) AsCl (3) S (4), a = 13.5942 (2) A, b = 7.7007 (1) A, c = 18.1270 (3) A, beta = 111.1662 (5) degrees, monoclinic, P2 (1)()/n, Z = 4; [(AsCl (3))(2)([16] aneSe (4))], C (12) H (24) As (2) Cl (6) Se (4), a = 9.764 (3) A, b = 13.164 (1) A, c = 10.627 (2) A, beta = 114.90 (1) degrees, monoclinic, P2 (1)()/n, Z = 2; [(AsBr (3))(2)([16] aneSe (4))], C (12) H (24) As (2) Br (6) Se (4), a = 10.1220 (1) A, b = 13.4494 (2) A, c = 10.5125 (2) A, beta = 113.49 (2) degrees, monoclinic, P2 (1)()/n, Z = 2. [AsBr (3)[MeS (CH (2))(2) SMe]] and [AsI (3)[MeS (CH (2))(2) SMe]] reveal discrete mu (2)-halo As (2) X (6) dimeric structures involving distorted octahedral As (III), with the dithioether ligand chelating. [AsCl (3)([9] aneS (3))] adopts a discrete molecular distorted octahedral geometry with the thioether behaving as a weakly coordinated fac-capping ligand. [AsCl (3)([14] aneS (4))] forms an infinite sheet involving two mu (2)-chloro ligands on each As but bridging to two distinct As centers. Each macrocycle coordinates to two adjacent As centers via one S atom, giving a cis-octahedral Cl (4) S (2) donor set at As (III). The structures of [(AsCl (3))(2)([16] aneSe (4))] and [(AsBr (3))(2)([16] aneSe (4))] adopt 2-dimensional sheet structures with mu (2)-dihalo As (2) X (6) dimers cross-linked by mu (4)-tetraselenoether macrocycles, giving a disorted cis-X (4) Se (2) donor set at each As center. These species are compared with their antimony (III) and bismuth (III) analogues where appropriate. |
31(0,1,1,1) |